Intuitive Surgical, Inc. $ISRG Shares Acquired by Jacobs & Co. CA

Key Points

• Jacobs & Co. CA increased its Intuitive Surgical stake by 12.5% in the third quarter, bringing its holdings to 29,299 shares valued at approximately $11.9 million. Institutional investors collectively own 83.64% of the company.
• Insiders sold 12,370 shares worth about $4.9 million in the last quarter under pre-arranged Rule 10b5-1 plans, while corporate insiders retain only 0.60% of the stock.
• Wall Street remains broadly positive, with a consensus “Moderate Buy” rating and a $502.53 price target. Intuitive Surgical also exceeded quarterly earnings and revenue expectations, reporting $2.80 in EPS and $2.89 billion in revenue, up 18.4% year over year.

Jacobs & Co. CA lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,299 shares of the medical equipment provider's stock after purchasing an additional 3,256 shares during the quarter. Jacobs & Co. CA's holdings in Intuitive Surgical were worth $11,913,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Valley Wealth Managers Inc. boosted its holdings in Intuitive Surgical by 2.4% in the 3rd quarter. Valley Wealth Managers Inc. now owns 4,954 shares of the medical equipment provider's stock valued at $2,014,000 after purchasing an additional 115 shares in the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI lifted its holdings in shares of Intuitive Surgical by 6.4% in the 3rd quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 41,642 shares of the medical equipment provider's stock valued at $16,933,000 after buying an additional 2,512 shares during the period. Atlas Brown Inc. lifted its holdings in shares of Intuitive Surgical by 6.0% in the 3rd quarter. Atlas Brown Inc. now owns 563 shares of the medical equipment provider's stock valued at $229,000 after buying an additional 32 shares during the period. Sound Income Strategies LLC purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $439,000. Finally, GK Wealth Management LLC purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $126,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Amy L. Ladd sold 72 shares of the company's stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the sale, the director directly owned 179 shares in the company, valued at $70,364.90. This represents a 28.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the sale, the director directly owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock worth $4,891,989 in the last quarter. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of several research analyst reports. Piper Sandler reiterated an "overweight" rating on shares of Intuitive Surgical in a research report on Friday, August 21st. Stifel Nicolaus lowered their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a "buy" rating on the stock in a research note on Friday, July 17th. Sanford C. Bernstein reissued an "outperform" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. KeyCorp restated an "overweight" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, BNP Paribas Exane raised Intuitive Surgical to an "outperform" rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus price target of $502.53.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays upgraded Intuitive Surgical to “strong buy” and initiated coverage at “overweight,” citing the company’s high-quality healthcare-equipment business despite a softer medical-device market. The bullish rating provides a near-term catalyst for the shares. Barclays initiates coverage of Intuitive Surgical
• Positive Sentiment: Piper Sandler also assigned a Buy rating, reinforcing favorable sell-side sentiment around ISRG. Intuitive Surgical gets a Buy from Piper Sandler
• Positive Sentiment: The company’s single-port robotic platform is gaining momentum, with rising procedures, utilization and system placements. Expanding medical indications and international adoption could support longer-term revenue growth. Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Analysts’ average recommendation remains bullish, but commentary warns that consensus ratings can be overly optimistic and that ISRG’s valuation leaves limited room for disappointment. Is Intuitive Surgical a Buy as Wall Street Analysts Look Optimistic?
• Neutral Sentiment: A reported short-interest figure of zero shares and a zero-day days-to-cover ratio suggests the latest short-interest data may be incomplete or erroneous, limiting its usefulness as a trading signal.
• Negative Sentiment: Jim Cramer expressed concern that Johnson & Johnson and other rivals could intensify competition in robotic surgery, potentially pressuring ISRG’s long-term market position. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $423.96 on Friday. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The company has a market capitalization of $149.78 billion, a PE ratio of 48.56, a price-to-earnings-growth ratio of 3.13 and a beta of 1.46. The firm's 50-day moving average is $386.36 and its two-hundred day moving average is $411.26.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the business earned $1.81 earnings per share. The company's quarterly revenue was up 18.4% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.